Xantis Pharma is making its mark, changing the landscape in the markets where it operates. Building on global pharmaceutical experience, our vision is to create a fully integrated pharmaceutical company and be a leading force in the markets we enter. We are well on our way, with a strong brand presence and a wide range of generic prescription and over-the-counter products.
| Website | http://www.xantispharma.com/en |
| Revenue | $24.4 million |
| Employees | 47 (8 on RocketReach) |
| Founded | 2015 |
| Phone | +41 41 620 80 00 |
| Technologies |
JavaScript
,
HTML
,
Google Analytics
+8 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Pharmaceuticals, Manufacturing |
| Keywords | Healthcare, Pharmaceutical Research, Drug Development, Biotechnology, Biopharmaceutical, Global Pharma, Pharmaceutical Manufacturing, Clinical Trials, Treatment, Drug Discovery, New Drug Applications, Health Tech, Prescription Drugs, Fda Approval, Regulatory Affairs, Market Access, Generic Drugs, Pharmaceutical Sales |
| Competitors | Roche, Novartis, Pfizer, Sanofi, GSK, Bristol Myers Squibb, Boehringer Ingelheim, Teva Pharmaceuticals, Lilly India, Mylan Belgium +34 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Xantis Pharma AG employee's phone or email?
The Xantis Pharma AG annual revenue was $24.4 million in 2026.
Tim Oreskovic is the CEO of Xantis Pharma AG.
8 people are employed at Xantis Pharma AG.
Xantis Pharma AG is based in Prague, Prague.
The NAICS codes for Xantis Pharma AG are [325, 32, 3254, 32541].
The SIC codes for Xantis Pharma AG are [283, 28].